7[12]Rubin R,Baserga R.Insulin-like growth factor-I receptor:its role in cell Proliferation[J].apoptosis and tumorigenicity Lab Invest,1995,73:311～331. 被引量：1
8[13]Foncea R,Andersson M,Kettorman A,et al.Insulinlike growth factor-I activates multiple signal transduction pathways in cultured rat cardiac myocytes [J].J Biol Chen,1997,272:19115～19214. 被引量：1
9[14]Sacca L,Ciltadini A,Fazio S.Growth hormone and the heart [J].Endocr Rev,1994,15:555 ～573. 被引量：1
10[15]Gomberg MM,Frishman WH,Bronx MD.Recombinant growth hormone:A new cardiovascular drug therapy[J].Am heart J,1996,132(6):1244～1262. 被引量：1
2Reh CS, Geffner ME. Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review. Clin Pharmacol, 2010, 2 : 111-122. 被引量：1
3Mauras N, Haymond MW. Are the metabolic effects of GH and IGF-1 separable? Growth Horm IGF Res, 2005, 15 (1) : 19- 27. 被引量：1
4Jeschke MG, Mlcak RP, Finnerty CC, et al. Burn size determines the inflammatory and hypermetabolic response. Crit Care, 2007, 11(4) : R90. 被引量：1
5Jeschke MG, Barrow RE, Mlcak RP, et al. Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences. Ann Surg, 2005, 241(5): 759-768. 被引量：1
6Jeschke MG,Mlcak RP, Finnerty CC, et al. Gender differences in pediatric burn patients: does it make a difference? Ann Surg, 2008, 248(1) : 126-136. 被引量：1
7Gauqlitz GG, Herndon DN, Kulp GA, et al. Abnormal insulin sensitivity persists up to three years in pediatric patients postburn. J Clin Endocrinol Metab,2009,94(5) :1656-1664. 被引量：1
8Jeschke MG, Gauqlitz GG, Kulp GA, et al. Long-term persis- tance of the pathophysiologic response to severe burn injury. PLoS One, 2011,6(7) : e21245. 被引量：1
9Przkora R, Barrow RE, Jeschke MG, et al. Body composition changes with time in pediatric burn patients. J Trauma, 2006, 60 (5) : 968-971. 被引量：1
